ARTICLE | Company News
BioChem Pharma divestiture
March 15, 2000 8:00 AM UTC
BioChem Pharma (BCHE; TSE:BCH) completed the previously announced divestiture of its ImmunoSystems diagnostics division. ImmunoSystems' management group assumed ownership and invested $5 million. BCHE...